Global Botanical Drug Supply, Demand and Key Producers, 2023-2029
The global Botanical Drug market size is expected to reach $ 51370 million by 2029, rising at a market growth of 4.6% CAGR during the forecast period (2023-2029).
Global 5 largest manufacturers of Botanical Drug are Buchang Pharmaceuticals, China TCM, Tsumura, Schwabe and Tong Ren Tang, which make up over 20%.
China is the largest market, with a share over 60%. In terms of product type, OTC occupy the largest share of the total market, over 60%. And in terms of application, the largest application is Cardiovascular, followed by Respiratory System and Tumor.
A botanical drug product is intended for use in the diagnosis, cure, mitigation, treatment or prevention of disease in humans.
A botanical drug product consists of vegetable materials, which may include plant materials, algae, macroscopic fungi, or combinations thereof.
A botanical drug product may be available as (but not limited to) a solution, powder, tablet, capsule, elixir, topical, or injection.
Botanical drug products often have unique features, for example, complex mixtures, lack of a distinct active ingredient, and substantial prior human use. Fermentation products and highly purified or chemically modified botanical substances are not considered botanical drug products.
This report studies the global Botanical Drug demand, key companies, and key regions.
This report is a detailed and comprehensive analysis of the world market for Botanical Drug, and provides market size (US$ million) and Year-over-Year (YoY) growth, considering 2022 as the base year. This report explores demand trends and competition, as well as details the characteristics of Botanical Drug that contribute to its increasing demand across many markets.
Highlights and key features of the study
Global Botanical Drug total market, 2018-2029, (USD Million)
Global Botanical Drug total market by region & country, CAGR, 2018-2029, (USD Million)
U.S. VS China: Botanical Drug total market, key domestic companies and share, (USD Million)
Global Botanical Drug revenue by player and market share 2018-2023, (USD Million)
Global Botanical Drug total market by Type, CAGR, 2018-2029, (USD Million)
Global Botanical Drug total market by Application, CAGR, 2018-2029, (USD Million).
This reports profiles major players in the global Botanical Drug market based on the following parameters – company overview, revenue, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Buchang Pharmaceuticals, China TCM, Tsumura, Schwabe, Tong Ren Tang, Jumpcan Pharmaceutical, Guangzhou Baiyunshan Pharmaceutical, Yunnan Baiyao and Tasly Holding Group, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the World Botanical Drug market.
Detailed Segmentation:
Each section contains quantitative market data including market by value (US$ Millions), by player, by regions, by Type, and by Application. Data is given for the years 2018-2029 by year with 2022 as the base year, 2023 as the estimate year, and 2024-2029 as the forecast year.
Global Botanical Drug Market, By Region:
1. How big is the global Botanical Drug market?
2. What is the demand of the global Botanical Drug market?
3. What is the year over year growth of the global Botanical Drug market?
4. What is the total value of the global Botanical Drug market?
5. Who are the major players in the global Botanical Drug market?
Global 5 largest manufacturers of Botanical Drug are Buchang Pharmaceuticals, China TCM, Tsumura, Schwabe and Tong Ren Tang, which make up over 20%.
China is the largest market, with a share over 60%. In terms of product type, OTC occupy the largest share of the total market, over 60%. And in terms of application, the largest application is Cardiovascular, followed by Respiratory System and Tumor.
A botanical drug product is intended for use in the diagnosis, cure, mitigation, treatment or prevention of disease in humans.
A botanical drug product consists of vegetable materials, which may include plant materials, algae, macroscopic fungi, or combinations thereof.
A botanical drug product may be available as (but not limited to) a solution, powder, tablet, capsule, elixir, topical, or injection.
Botanical drug products often have unique features, for example, complex mixtures, lack of a distinct active ingredient, and substantial prior human use. Fermentation products and highly purified or chemically modified botanical substances are not considered botanical drug products.
This report studies the global Botanical Drug demand, key companies, and key regions.
This report is a detailed and comprehensive analysis of the world market for Botanical Drug, and provides market size (US$ million) and Year-over-Year (YoY) growth, considering 2022 as the base year. This report explores demand trends and competition, as well as details the characteristics of Botanical Drug that contribute to its increasing demand across many markets.
Highlights and key features of the study
Global Botanical Drug total market, 2018-2029, (USD Million)
Global Botanical Drug total market by region & country, CAGR, 2018-2029, (USD Million)
U.S. VS China: Botanical Drug total market, key domestic companies and share, (USD Million)
Global Botanical Drug revenue by player and market share 2018-2023, (USD Million)
Global Botanical Drug total market by Type, CAGR, 2018-2029, (USD Million)
Global Botanical Drug total market by Application, CAGR, 2018-2029, (USD Million).
This reports profiles major players in the global Botanical Drug market based on the following parameters – company overview, revenue, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Buchang Pharmaceuticals, China TCM, Tsumura, Schwabe, Tong Ren Tang, Jumpcan Pharmaceutical, Guangzhou Baiyunshan Pharmaceutical, Yunnan Baiyao and Tasly Holding Group, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the World Botanical Drug market.
Detailed Segmentation:
Each section contains quantitative market data including market by value (US$ Millions), by player, by regions, by Type, and by Application. Data is given for the years 2018-2029 by year with 2022 as the base year, 2023 as the estimate year, and 2024-2029 as the forecast year.
Global Botanical Drug Market, By Region:
- United States
- China
- Europe
- Japan
- South Korea
- ASEAN
- India
- Rest of World
- Prescription Drug
- OTC
- Cardiovascular
- Tumor
- Respiratory System
- Other
- Buchang Pharmaceuticals
- China TCM
- Tsumura
- Schwabe
- Tong Ren Tang
- Jumpcan Pharmaceutical
- Guangzhou Baiyunshan Pharmaceutical
- Yunnan Baiyao
- Tasly Holding Group
- Bionorica Se
- Huarun 999
- Taiji
- Weleda
- Kwangdong
- GW Pharmaceuticals
1. How big is the global Botanical Drug market?
2. What is the demand of the global Botanical Drug market?
3. What is the year over year growth of the global Botanical Drug market?
4. What is the total value of the global Botanical Drug market?
5. Who are the major players in the global Botanical Drug market?
1 SUPPLY SUMMARY
1.1 Botanical Drug Introduction
1.2 World Botanical Drug Market Size & Forecast (2018 & 2022 & 2029)
1.3 World Botanical Drug Total Market by Region (by Headquarter Location)
1.3.1 World Botanical Drug Market Size by Region (2018-2029), (by Headquarter Location)
1.3.2 United States Botanical Drug Market Size (2018-2029)
1.3.3 China Botanical Drug Market Size (2018-2029)
1.3.4 Europe Botanical Drug Market Size (2018-2029)
1.3.5 Japan Botanical Drug Market Size (2018-2029)
1.3.6 South Korea Botanical Drug Market Size (2018-2029)
1.3.7 ASEAN Botanical Drug Market Size (2018-2029)
1.3.8 India Botanical Drug Market Size (2018-2029)
1.4 Market Drivers, Restraints and Trends
1.4.1 Botanical Drug Market Drivers
1.4.2 Factors Affecting Demand
1.4.3 Botanical Drug Major Market Trends
2 DEMAND SUMMARY
2.1 World Botanical Drug Consumption Value (2018-2029)
2.2 World Botanical Drug Consumption Value by Region
2.2.1 World Botanical Drug Consumption Value by Region (2018-2023)
2.2.2 World Botanical Drug Consumption Value Forecast by Region (2024-2029)
2.3 United States Botanical Drug Consumption Value (2018-2029)
2.4 China Botanical Drug Consumption Value (2018-2029)
2.5 Europe Botanical Drug Consumption Value (2018-2029)
2.6 Japan Botanical Drug Consumption Value (2018-2029)
2.7 South Korea Botanical Drug Consumption Value (2018-2029)
2.8 ASEAN Botanical Drug Consumption Value (2018-2029)
2.9 India Botanical Drug Consumption Value (2018-2029)
3 WORLD BOTANICAL DRUG COMPANIES COMPETITIVE ANALYSIS
3.1 World Botanical Drug Revenue by Player (2018-2023)
3.2 Industry Rank and Concentration Rate (CR)
3.2.1 Global Botanical Drug Industry Rank of Major Players
3.2.2 Global Concentration Ratios (CR4) for Botanical Drug in 2022
3.2.3 Global Concentration Ratios (CR8) for Botanical Drug in 2022
3.3 Botanical Drug Company Evaluation Quadrant
3.4 Botanical Drug Market: Overall Company Footprint Analysis
3.4.1 Botanical Drug Market: Region Footprint
3.4.2 Botanical Drug Market: Company Product Type Footprint
3.4.3 Botanical Drug Market: Company Product Application Footprint
3.5 Competitive Environment
3.5.1 Historical Structure of the Industry
3.5.2 Barriers of Market Entry
3.5.3 Factors of Competition
3.6 Mergers, Acquisitions Activity
4 UNITED STATES VS CHINA VS REST OF THE WORLD (BY HEADQUARTER LOCATION)
4.1 United States VS China: Botanical Drug Revenue Comparison (by Headquarter Location)
4.1.1 United States VS China: Botanical Drug Market Size Comparison (2018 & 2022 & 2029) (by Headquarter Location)
4.1.2 United States VS China: Botanical Drug Revenue Market Share Comparison (2018 & 2022 & 2029)
4.2 United States Based Companies VS China Based Companies: Botanical Drug Consumption Value Comparison
4.2.1 United States VS China: Botanical Drug Consumption Value Comparison (2018 & 2022 & 2029)
4.2.2 United States VS China: Botanical Drug Consumption Value Market Share Comparison (2018 & 2022 & 2029)
4.3 United States Based Botanical Drug Companies and Market Share, 2018-2023
4.3.1 United States Based Botanical Drug Companies, Headquarters (States, Country)
4.3.2 United States Based Companies Botanical Drug Revenue, (2018-2023)
4.4 China Based Companies Botanical Drug Revenue and Market Share, 2018-2023
4.4.1 China Based Botanical Drug Companies, Company Headquarters (Province, Country)
4.4.2 China Based Companies Botanical Drug Revenue, (2018-2023)
4.5 Rest of World Based Botanical Drug Companies and Market Share, 2018-2023
4.5.1 Rest of World Based Botanical Drug Companies, Headquarters (States, Country)
4.5.2 Rest of World Based Companies Botanical Drug Revenue, (2018-2023)
5 MARKET ANALYSIS BY TYPE
5.1 World Botanical Drug Market Size Overview by Type: 2018 VS 2022 VS 2029
5.2 Segment Introduction by Type
5.2.1 Prescription Drug
5.2.2 OTC
5.3 Market Segment by Type
5.3.1 World Botanical Drug Market Size by Type (2018-2023)
5.3.2 World Botanical Drug Market Size by Type (2024-2029)
5.3.3 World Botanical Drug Market Size Market Share by Type (2018-2029)
6 MARKET ANALYSIS BY APPLICATION
6.1 World Botanical Drug Market Size Overview by Application: 2018 VS 2022 VS 2029
6.2 Segment Introduction by Application
6.2.1 Cardiovascular
6.2.2 Tumor
6.2.3 Respiratory System
6.2.4 Other
6.2.5 Other
6.3 Market Segment by Application
6.3.1 World Botanical Drug Market Size by Application (2018-2023)
6.3.2 World Botanical Drug Market Size by Application (2024-2029)
6.3.3 World Botanical Drug Market Size by Application (2018-2029)
7 COMPANY PROFILES
7.1 Buchang Pharmaceuticals
7.1.1 Buchang Pharmaceuticals Details
7.1.2 Buchang Pharmaceuticals Major Business
7.1.3 Buchang Pharmaceuticals Botanical Drug Product and Services
7.1.4 Buchang Pharmaceuticals Botanical Drug Revenue, Gross Margin and Market Share (2018-2023)
7.1.5 Buchang Pharmaceuticals Recent Developments/Updates
7.1.6 Buchang Pharmaceuticals Competitive Strengths & Weaknesses
7.2 China TCM
7.2.1 China TCM Details
7.2.2 China TCM Major Business
7.2.3 China TCM Botanical Drug Product and Services
7.2.4 China TCM Botanical Drug Revenue, Gross Margin and Market Share (2018-2023)
7.2.5 China TCM Recent Developments/Updates
7.2.6 China TCM Competitive Strengths & Weaknesses
7.3 Tsumura
7.3.1 Tsumura Details
7.3.2 Tsumura Major Business
7.3.3 Tsumura Botanical Drug Product and Services
7.3.4 Tsumura Botanical Drug Revenue, Gross Margin and Market Share (2018-2023)
7.3.5 Tsumura Recent Developments/Updates
7.3.6 Tsumura Competitive Strengths & Weaknesses
7.4 Schwabe
7.4.1 Schwabe Details
7.4.2 Schwabe Major Business
7.4.3 Schwabe Botanical Drug Product and Services
7.4.4 Schwabe Botanical Drug Revenue, Gross Margin and Market Share (2018-2023)
7.4.5 Schwabe Recent Developments/Updates
7.4.6 Schwabe Competitive Strengths & Weaknesses
7.5 Tong Ren Tang
7.5.1 Tong Ren Tang Details
7.5.2 Tong Ren Tang Major Business
7.5.3 Tong Ren Tang Botanical Drug Product and Services
7.5.4 Tong Ren Tang Botanical Drug Revenue, Gross Margin and Market Share (2018-2023)
7.5.5 Tong Ren Tang Recent Developments/Updates
7.5.6 Tong Ren Tang Competitive Strengths & Weaknesses
7.6 Jumpcan Pharmaceutical
7.6.1 Jumpcan Pharmaceutical Details
7.6.2 Jumpcan Pharmaceutical Major Business
7.6.3 Jumpcan Pharmaceutical Botanical Drug Product and Services
7.6.4 Jumpcan Pharmaceutical Botanical Drug Revenue, Gross Margin and Market Share (2018-2023)
7.6.5 Jumpcan Pharmaceutical Recent Developments/Updates
7.6.6 Jumpcan Pharmaceutical Competitive Strengths & Weaknesses
7.7 Guangzhou Baiyunshan Pharmaceutical
7.7.1 Guangzhou Baiyunshan Pharmaceutical Details
7.7.2 Guangzhou Baiyunshan Pharmaceutical Major Business
7.7.3 Guangzhou Baiyunshan Pharmaceutical Botanical Drug Product and Services
7.7.4 Guangzhou Baiyunshan Pharmaceutical Botanical Drug Revenue, Gross Margin and Market Share (2018-2023)
7.7.5 Guangzhou Baiyunshan Pharmaceutical Recent Developments/Updates
7.7.6 Guangzhou Baiyunshan Pharmaceutical Competitive Strengths & Weaknesses
7.8 Yunnan Baiyao
7.8.1 Yunnan Baiyao Details
7.8.2 Yunnan Baiyao Major Business
7.8.3 Yunnan Baiyao Botanical Drug Product and Services
7.8.4 Yunnan Baiyao Botanical Drug Revenue, Gross Margin and Market Share (2018-2023)
7.8.5 Yunnan Baiyao Recent Developments/Updates
7.8.6 Yunnan Baiyao Competitive Strengths & Weaknesses
7.9 Tasly Holding Group
7.9.1 Tasly Holding Group Details
7.9.2 Tasly Holding Group Major Business
7.9.3 Tasly Holding Group Botanical Drug Product and Services
7.9.4 Tasly Holding Group Botanical Drug Revenue, Gross Margin and Market Share (2018-2023)
7.9.5 Tasly Holding Group Recent Developments/Updates
7.9.6 Tasly Holding Group Competitive Strengths & Weaknesses
7.10 Bionorica Se
7.10.1 Bionorica Se Details
7.10.2 Bionorica Se Major Business
7.10.3 Bionorica Se Botanical Drug Product and Services
7.10.4 Bionorica Se Botanical Drug Revenue, Gross Margin and Market Share (2018-2023)
7.10.5 Bionorica Se Recent Developments/Updates
7.10.6 Bionorica Se Competitive Strengths & Weaknesses
7.11 Huarun
7.11.1 Huarun 999 Details
7.11.2 Huarun 999 Major Business
7.11.3 Huarun 999 Botanical Drug Product and Services
7.11.4 Huarun 999 Botanical Drug Revenue, Gross Margin and Market Share (2018-2023)
7.11.5 Huarun 999 Recent Developments/Updates
7.11.6 Huarun 999 Competitive Strengths & Weaknesses
7.12 Taiji
7.12.1 Taiji Details
7.12.2 Taiji Major Business
7.12.3 Taiji Botanical Drug Product and Services
7.12.4 Taiji Botanical Drug Revenue, Gross Margin and Market Share (2018-2023)
7.12.5 Taiji Recent Developments/Updates
7.12.6 Taiji Competitive Strengths & Weaknesses
7.13 Weleda
7.13.1 Weleda Details
7.13.2 Weleda Major Business
7.13.3 Weleda Botanical Drug Product and Services
7.13.4 Weleda Botanical Drug Revenue, Gross Margin and Market Share (2018-2023)
7.13.5 Weleda Recent Developments/Updates
7.13.6 Weleda Competitive Strengths & Weaknesses
7.14 Kwangdong
7.14.1 Kwangdong Details
7.14.2 Kwangdong Major Business
7.14.3 Kwangdong Botanical Drug Product and Services
7.14.4 Kwangdong Botanical Drug Revenue, Gross Margin and Market Share (2018-2023)
7.14.5 Kwangdong Recent Developments/Updates
7.14.6 Kwangdong Competitive Strengths & Weaknesses
7.15 GW Pharmaceuticals
7.15.1 GW Pharmaceuticals Details
7.15.2 GW Pharmaceuticals Major Business
7.15.3 GW Pharmaceuticals Botanical Drug Product and Services
7.15.4 GW Pharmaceuticals Botanical Drug Revenue, Gross Margin and Market Share (2018-2023)
7.15.5 GW Pharmaceuticals Recent Developments/Updates
7.15.6 GW Pharmaceuticals Competitive Strengths & Weaknesses
8 INDUSTRY CHAIN ANALYSIS
8.1 Botanical Drug Industry Chain
8.2 Botanical Drug Upstream Analysis
8.3 Botanical Drug Midstream Analysis
8.4 Botanical Drug Downstream Analysis
9 RESEARCH FINDINGS AND CONCLUSION
10 APPENDIX
10.1 Methodology
10.2 Research Process and Data Source
10.3 Disclaimer
1.1 Botanical Drug Introduction
1.2 World Botanical Drug Market Size & Forecast (2018 & 2022 & 2029)
1.3 World Botanical Drug Total Market by Region (by Headquarter Location)
1.3.1 World Botanical Drug Market Size by Region (2018-2029), (by Headquarter Location)
1.3.2 United States Botanical Drug Market Size (2018-2029)
1.3.3 China Botanical Drug Market Size (2018-2029)
1.3.4 Europe Botanical Drug Market Size (2018-2029)
1.3.5 Japan Botanical Drug Market Size (2018-2029)
1.3.6 South Korea Botanical Drug Market Size (2018-2029)
1.3.7 ASEAN Botanical Drug Market Size (2018-2029)
1.3.8 India Botanical Drug Market Size (2018-2029)
1.4 Market Drivers, Restraints and Trends
1.4.1 Botanical Drug Market Drivers
1.4.2 Factors Affecting Demand
1.4.3 Botanical Drug Major Market Trends
2 DEMAND SUMMARY
2.1 World Botanical Drug Consumption Value (2018-2029)
2.2 World Botanical Drug Consumption Value by Region
2.2.1 World Botanical Drug Consumption Value by Region (2018-2023)
2.2.2 World Botanical Drug Consumption Value Forecast by Region (2024-2029)
2.3 United States Botanical Drug Consumption Value (2018-2029)
2.4 China Botanical Drug Consumption Value (2018-2029)
2.5 Europe Botanical Drug Consumption Value (2018-2029)
2.6 Japan Botanical Drug Consumption Value (2018-2029)
2.7 South Korea Botanical Drug Consumption Value (2018-2029)
2.8 ASEAN Botanical Drug Consumption Value (2018-2029)
2.9 India Botanical Drug Consumption Value (2018-2029)
3 WORLD BOTANICAL DRUG COMPANIES COMPETITIVE ANALYSIS
3.1 World Botanical Drug Revenue by Player (2018-2023)
3.2 Industry Rank and Concentration Rate (CR)
3.2.1 Global Botanical Drug Industry Rank of Major Players
3.2.2 Global Concentration Ratios (CR4) for Botanical Drug in 2022
3.2.3 Global Concentration Ratios (CR8) for Botanical Drug in 2022
3.3 Botanical Drug Company Evaluation Quadrant
3.4 Botanical Drug Market: Overall Company Footprint Analysis
3.4.1 Botanical Drug Market: Region Footprint
3.4.2 Botanical Drug Market: Company Product Type Footprint
3.4.3 Botanical Drug Market: Company Product Application Footprint
3.5 Competitive Environment
3.5.1 Historical Structure of the Industry
3.5.2 Barriers of Market Entry
3.5.3 Factors of Competition
3.6 Mergers, Acquisitions Activity
4 UNITED STATES VS CHINA VS REST OF THE WORLD (BY HEADQUARTER LOCATION)
4.1 United States VS China: Botanical Drug Revenue Comparison (by Headquarter Location)
4.1.1 United States VS China: Botanical Drug Market Size Comparison (2018 & 2022 & 2029) (by Headquarter Location)
4.1.2 United States VS China: Botanical Drug Revenue Market Share Comparison (2018 & 2022 & 2029)
4.2 United States Based Companies VS China Based Companies: Botanical Drug Consumption Value Comparison
4.2.1 United States VS China: Botanical Drug Consumption Value Comparison (2018 & 2022 & 2029)
4.2.2 United States VS China: Botanical Drug Consumption Value Market Share Comparison (2018 & 2022 & 2029)
4.3 United States Based Botanical Drug Companies and Market Share, 2018-2023
4.3.1 United States Based Botanical Drug Companies, Headquarters (States, Country)
4.3.2 United States Based Companies Botanical Drug Revenue, (2018-2023)
4.4 China Based Companies Botanical Drug Revenue and Market Share, 2018-2023
4.4.1 China Based Botanical Drug Companies, Company Headquarters (Province, Country)
4.4.2 China Based Companies Botanical Drug Revenue, (2018-2023)
4.5 Rest of World Based Botanical Drug Companies and Market Share, 2018-2023
4.5.1 Rest of World Based Botanical Drug Companies, Headquarters (States, Country)
4.5.2 Rest of World Based Companies Botanical Drug Revenue, (2018-2023)
5 MARKET ANALYSIS BY TYPE
5.1 World Botanical Drug Market Size Overview by Type: 2018 VS 2022 VS 2029
5.2 Segment Introduction by Type
5.2.1 Prescription Drug
5.2.2 OTC
5.3 Market Segment by Type
5.3.1 World Botanical Drug Market Size by Type (2018-2023)
5.3.2 World Botanical Drug Market Size by Type (2024-2029)
5.3.3 World Botanical Drug Market Size Market Share by Type (2018-2029)
6 MARKET ANALYSIS BY APPLICATION
6.1 World Botanical Drug Market Size Overview by Application: 2018 VS 2022 VS 2029
6.2 Segment Introduction by Application
6.2.1 Cardiovascular
6.2.2 Tumor
6.2.3 Respiratory System
6.2.4 Other
6.2.5 Other
6.3 Market Segment by Application
6.3.1 World Botanical Drug Market Size by Application (2018-2023)
6.3.2 World Botanical Drug Market Size by Application (2024-2029)
6.3.3 World Botanical Drug Market Size by Application (2018-2029)
7 COMPANY PROFILES
7.1 Buchang Pharmaceuticals
7.1.1 Buchang Pharmaceuticals Details
7.1.2 Buchang Pharmaceuticals Major Business
7.1.3 Buchang Pharmaceuticals Botanical Drug Product and Services
7.1.4 Buchang Pharmaceuticals Botanical Drug Revenue, Gross Margin and Market Share (2018-2023)
7.1.5 Buchang Pharmaceuticals Recent Developments/Updates
7.1.6 Buchang Pharmaceuticals Competitive Strengths & Weaknesses
7.2 China TCM
7.2.1 China TCM Details
7.2.2 China TCM Major Business
7.2.3 China TCM Botanical Drug Product and Services
7.2.4 China TCM Botanical Drug Revenue, Gross Margin and Market Share (2018-2023)
7.2.5 China TCM Recent Developments/Updates
7.2.6 China TCM Competitive Strengths & Weaknesses
7.3 Tsumura
7.3.1 Tsumura Details
7.3.2 Tsumura Major Business
7.3.3 Tsumura Botanical Drug Product and Services
7.3.4 Tsumura Botanical Drug Revenue, Gross Margin and Market Share (2018-2023)
7.3.5 Tsumura Recent Developments/Updates
7.3.6 Tsumura Competitive Strengths & Weaknesses
7.4 Schwabe
7.4.1 Schwabe Details
7.4.2 Schwabe Major Business
7.4.3 Schwabe Botanical Drug Product and Services
7.4.4 Schwabe Botanical Drug Revenue, Gross Margin and Market Share (2018-2023)
7.4.5 Schwabe Recent Developments/Updates
7.4.6 Schwabe Competitive Strengths & Weaknesses
7.5 Tong Ren Tang
7.5.1 Tong Ren Tang Details
7.5.2 Tong Ren Tang Major Business
7.5.3 Tong Ren Tang Botanical Drug Product and Services
7.5.4 Tong Ren Tang Botanical Drug Revenue, Gross Margin and Market Share (2018-2023)
7.5.5 Tong Ren Tang Recent Developments/Updates
7.5.6 Tong Ren Tang Competitive Strengths & Weaknesses
7.6 Jumpcan Pharmaceutical
7.6.1 Jumpcan Pharmaceutical Details
7.6.2 Jumpcan Pharmaceutical Major Business
7.6.3 Jumpcan Pharmaceutical Botanical Drug Product and Services
7.6.4 Jumpcan Pharmaceutical Botanical Drug Revenue, Gross Margin and Market Share (2018-2023)
7.6.5 Jumpcan Pharmaceutical Recent Developments/Updates
7.6.6 Jumpcan Pharmaceutical Competitive Strengths & Weaknesses
7.7 Guangzhou Baiyunshan Pharmaceutical
7.7.1 Guangzhou Baiyunshan Pharmaceutical Details
7.7.2 Guangzhou Baiyunshan Pharmaceutical Major Business
7.7.3 Guangzhou Baiyunshan Pharmaceutical Botanical Drug Product and Services
7.7.4 Guangzhou Baiyunshan Pharmaceutical Botanical Drug Revenue, Gross Margin and Market Share (2018-2023)
7.7.5 Guangzhou Baiyunshan Pharmaceutical Recent Developments/Updates
7.7.6 Guangzhou Baiyunshan Pharmaceutical Competitive Strengths & Weaknesses
7.8 Yunnan Baiyao
7.8.1 Yunnan Baiyao Details
7.8.2 Yunnan Baiyao Major Business
7.8.3 Yunnan Baiyao Botanical Drug Product and Services
7.8.4 Yunnan Baiyao Botanical Drug Revenue, Gross Margin and Market Share (2018-2023)
7.8.5 Yunnan Baiyao Recent Developments/Updates
7.8.6 Yunnan Baiyao Competitive Strengths & Weaknesses
7.9 Tasly Holding Group
7.9.1 Tasly Holding Group Details
7.9.2 Tasly Holding Group Major Business
7.9.3 Tasly Holding Group Botanical Drug Product and Services
7.9.4 Tasly Holding Group Botanical Drug Revenue, Gross Margin and Market Share (2018-2023)
7.9.5 Tasly Holding Group Recent Developments/Updates
7.9.6 Tasly Holding Group Competitive Strengths & Weaknesses
7.10 Bionorica Se
7.10.1 Bionorica Se Details
7.10.2 Bionorica Se Major Business
7.10.3 Bionorica Se Botanical Drug Product and Services
7.10.4 Bionorica Se Botanical Drug Revenue, Gross Margin and Market Share (2018-2023)
7.10.5 Bionorica Se Recent Developments/Updates
7.10.6 Bionorica Se Competitive Strengths & Weaknesses
7.11 Huarun
7.11.1 Huarun 999 Details
7.11.2 Huarun 999 Major Business
7.11.3 Huarun 999 Botanical Drug Product and Services
7.11.4 Huarun 999 Botanical Drug Revenue, Gross Margin and Market Share (2018-2023)
7.11.5 Huarun 999 Recent Developments/Updates
7.11.6 Huarun 999 Competitive Strengths & Weaknesses
7.12 Taiji
7.12.1 Taiji Details
7.12.2 Taiji Major Business
7.12.3 Taiji Botanical Drug Product and Services
7.12.4 Taiji Botanical Drug Revenue, Gross Margin and Market Share (2018-2023)
7.12.5 Taiji Recent Developments/Updates
7.12.6 Taiji Competitive Strengths & Weaknesses
7.13 Weleda
7.13.1 Weleda Details
7.13.2 Weleda Major Business
7.13.3 Weleda Botanical Drug Product and Services
7.13.4 Weleda Botanical Drug Revenue, Gross Margin and Market Share (2018-2023)
7.13.5 Weleda Recent Developments/Updates
7.13.6 Weleda Competitive Strengths & Weaknesses
7.14 Kwangdong
7.14.1 Kwangdong Details
7.14.2 Kwangdong Major Business
7.14.3 Kwangdong Botanical Drug Product and Services
7.14.4 Kwangdong Botanical Drug Revenue, Gross Margin and Market Share (2018-2023)
7.14.5 Kwangdong Recent Developments/Updates
7.14.6 Kwangdong Competitive Strengths & Weaknesses
7.15 GW Pharmaceuticals
7.15.1 GW Pharmaceuticals Details
7.15.2 GW Pharmaceuticals Major Business
7.15.3 GW Pharmaceuticals Botanical Drug Product and Services
7.15.4 GW Pharmaceuticals Botanical Drug Revenue, Gross Margin and Market Share (2018-2023)
7.15.5 GW Pharmaceuticals Recent Developments/Updates
7.15.6 GW Pharmaceuticals Competitive Strengths & Weaknesses
8 INDUSTRY CHAIN ANALYSIS
8.1 Botanical Drug Industry Chain
8.2 Botanical Drug Upstream Analysis
8.3 Botanical Drug Midstream Analysis
8.4 Botanical Drug Downstream Analysis
9 RESEARCH FINDINGS AND CONCLUSION
10 APPENDIX
10.1 Methodology
10.2 Research Process and Data Source
10.3 Disclaimer
LIST OF TABLES
Table 1. World Botanical Drug Revenue by Region (2018, 2022 and 2029) & (USD Million), (by Headquarter Location)
Table 2. World Botanical Drug Revenue by Region (2018-2023) & (USD Million), (by Headquarter Location)
Table 3. World Botanical Drug Revenue by Region (2024-2029) & (USD Million), (by Headquarter Location)
Table 4. World Botanical Drug Revenue Market Share by Region (2018-2023), (by Headquarter Location)
Table 5. World Botanical Drug Revenue Market Share by Region (2024-2029), (by Headquarter Location)
Table 6. Major Market Trends
Table 7. World Botanical Drug Consumption Value Growth Rate Forecast by Region (2018 & 2022 & 2029) & (USD Million)
Table 8. World Botanical Drug Consumption Value by Region (2018-2023) & (USD Million)
Table 9. World Botanical Drug Consumption Value Forecast by Region (2024-2029) & (USD Million)
Table 10. World Botanical Drug Revenue by Player (2018-2023) & (USD Million)
Table 11. Revenue Market Share of Key Botanical Drug Players in 2022
Table 12. World Botanical Drug Industry Rank of Major Player, Based on Revenue in 2022
Table 13. Global Botanical Drug Company Evaluation Quadrant
Table 14. Head Office of Key Botanical Drug Player
Table 15. Botanical Drug Market: Company Product Type Footprint
Table 16. Botanical Drug Market: Company Product Application Footprint
Table 17. Botanical Drug Mergers & Acquisitions Activity
Table 18. United States VS China Botanical Drug Market Size Comparison, (2018 & 2022 & 2029) & (USD Million)
Table 19. United States VS China Botanical Drug Consumption Value Comparison, (2018 & 2022 & 2029) & (USD Million)
Table 20. United States Based Botanical Drug Companies, Headquarters (States, Country)
Table 21. United States Based Companies Botanical Drug Revenue, (2018-2023) & (USD Million)
Table 22. United States Based Companies Botanical Drug Revenue Market Share (2018-2023)
Table 23. China Based Botanical Drug Companies, Headquarters (Province, Country)
Table 24. China Based Companies Botanical Drug Revenue, (2018-2023) & (USD Million)
Table 25. China Based Companies Botanical Drug Revenue Market Share (2018-2023)
Table 26. Rest of World Based Botanical Drug Companies, Headquarters (States, Country)
Table 27. Rest of World Based Companies Botanical Drug Revenue, (2018-2023) & (USD Million)
Table 28. Rest of World Based Companies Botanical Drug Revenue Market Share (2018-2023)
Table 29. World Botanical Drug Market Size by Type, (USD Million), 2018 & 2022 & 2029
Table 30. World Botanical Drug Market Size by Type (2018-2023) & (USD Million)
Table 31. World Botanical Drug Market Size by Type (2024-2029) & (USD Million)
Table 32. World Botanical Drug Market Size by Application, (USD Million), 2018 & 2022 & 2029
Table 33. World Botanical Drug Market Size by Application (2018-2023) & (USD Million)
Table 34. World Botanical Drug Market Size by Application (2024-2029) & (USD Million)
Table 35. Buchang Pharmaceuticals Basic Information, Area Served and Competitors
Table 36. Buchang Pharmaceuticals Major Business
Table 37. Buchang Pharmaceuticals Botanical Drug Product and Services
Table 38. Buchang Pharmaceuticals Botanical Drug Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 39. Buchang Pharmaceuticals Recent Developments/Updates
Table 40. Buchang Pharmaceuticals Competitive Strengths & Weaknesses
Table 41. China TCM Basic Information, Area Served and Competitors
Table 42. China TCM Major Business
Table 43. China TCM Botanical Drug Product and Services
Table 44. China TCM Botanical Drug Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 45. China TCM Recent Developments/Updates
Table 46. China TCM Competitive Strengths & Weaknesses
Table 47. Tsumura Basic Information, Area Served and Competitors
Table 48. Tsumura Major Business
Table 49. Tsumura Botanical Drug Product and Services
Table 50. Tsumura Botanical Drug Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 51. Tsumura Recent Developments/Updates
Table 52. Tsumura Competitive Strengths & Weaknesses
Table 53. Schwabe Basic Information, Area Served and Competitors
Table 54. Schwabe Major Business
Table 55. Schwabe Botanical Drug Product and Services
Table 56. Schwabe Botanical Drug Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 57. Schwabe Recent Developments/Updates
Table 58. Schwabe Competitive Strengths & Weaknesses
Table 59. Tong Ren Tang Basic Information, Area Served and Competitors
Table 60. Tong Ren Tang Major Business
Table 61. Tong Ren Tang Botanical Drug Product and Services
Table 62. Tong Ren Tang Botanical Drug Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 63. Tong Ren Tang Recent Developments/Updates
Table 64. Tong Ren Tang Competitive Strengths & Weaknesses
Table 65. Jumpcan Pharmaceutical Basic Information, Area Served and Competitors
Table 66. Jumpcan Pharmaceutical Major Business
Table 67. Jumpcan Pharmaceutical Botanical Drug Product and Services
Table 68. Jumpcan Pharmaceutical Botanical Drug Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 69. Jumpcan Pharmaceutical Recent Developments/Updates
Table 70. Jumpcan Pharmaceutical Competitive Strengths & Weaknesses
Table 71. Guangzhou Baiyunshan Pharmaceutical Basic Information, Area Served and Competitors
Table 72. Guangzhou Baiyunshan Pharmaceutical Major Business
Table 73. Guangzhou Baiyunshan Pharmaceutical Botanical Drug Product and Services
Table 74. Guangzhou Baiyunshan Pharmaceutical Botanical Drug Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 75. Guangzhou Baiyunshan Pharmaceutical Recent Developments/Updates
Table 76. Guangzhou Baiyunshan Pharmaceutical Competitive Strengths & Weaknesses
Table 77. Yunnan Baiyao Basic Information, Area Served and Competitors
Table 78. Yunnan Baiyao Major Business
Table 79. Yunnan Baiyao Botanical Drug Product and Services
Table 80. Yunnan Baiyao Botanical Drug Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 81. Yunnan Baiyao Recent Developments/Updates
Table 82. Yunnan Baiyao Competitive Strengths & Weaknesses
Table 83. Tasly Holding Group Basic Information, Area Served and Competitors
Table 84. Tasly Holding Group Major Business
Table 85. Tasly Holding Group Botanical Drug Product and Services
Table 86. Tasly Holding Group Botanical Drug Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 87. Tasly Holding Group Recent Developments/Updates
Table 88. Tasly Holding Group Competitive Strengths & Weaknesses
Table 89. Bionorica Se Basic Information, Area Served and Competitors
Table 90. Bionorica Se Major Business
Table 91. Bionorica Se Botanical Drug Product and Services
Table 92. Bionorica Se Botanical Drug Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 93. Bionorica Se Recent Developments/Updates
Table 94. Bionorica Se Competitive Strengths & Weaknesses
Table 95. Huarun 999 Basic Information, Area Served and Competitors
Table 96. Huarun 999 Major Business
Table 97. Huarun 999 Botanical Drug Product and Services
Table 98. Huarun 999 Botanical Drug Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 99. Huarun 999 Recent Developments/Updates
Table 100. Huarun 999 Competitive Strengths & Weaknesses
Table 101. Taiji Basic Information, Area Served and Competitors
Table 102. Taiji Major Business
Table 103. Taiji Botanical Drug Product and Services
Table 104. Taiji Botanical Drug Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 105. Taiji Recent Developments/Updates
Table 106. Taiji Competitive Strengths & Weaknesses
Table 107. Weleda Basic Information, Area Served and Competitors
Table 108. Weleda Major Business
Table 109. Weleda Botanical Drug Product and Services
Table 110. Weleda Botanical Drug Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 111. Weleda Recent Developments/Updates
Table 112. Weleda Competitive Strengths & Weaknesses
Table 113. Kwangdong Basic Information, Area Served and Competitors
Table 114. Kwangdong Major Business
Table 115. Kwangdong Botanical Drug Product and Services
Table 116. Kwangdong Botanical Drug Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 117. Kwangdong Recent Developments/Updates
Table 118. GW Pharmaceuticals Basic Information, Area Served and Competitors
Table 119. GW Pharmaceuticals Major Business
Table 120. GW Pharmaceuticals Botanical Drug Product and Services
Table 121. GW Pharmaceuticals Botanical Drug Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 122. Global Key Players of Botanical Drug Upstream (Raw Materials)
Table 123. Botanical Drug Typical Customers
LIST OF FIGURE
Figure 1. Botanical Drug Picture
Figure 2. World Botanical Drug Total Market Size: 2018 & 2022 & 2029, (USD Million)
Figure 3. World Botanical Drug Total Market Size (2018-2029) & (USD Million)
Figure 4. World Botanical Drug Revenue Market Share by Region (2018, 2022 and 2029) & (USD Million) , (by Headquarter Location)
Figure 5. World Botanical Drug Revenue Market Share by Region (2018-2029), (by Headquarter Location)
Figure 6. United States Based Company Botanical Drug Revenue (2018-2029) & (USD Million)
Figure 7. China Based Company Botanical Drug Revenue (2018-2029) & (USD Million)
Figure 8. Europe Based Company Botanical Drug Revenue (2018-2029) & (USD Million)
Figure 9. Japan Based Company Botanical Drug Revenue (2018-2029) & (USD Million)
Figure 10. South Korea Based Company Botanical Drug Revenue (2018-2029) & (USD Million)
Figure 11. ASEAN Based Company Botanical Drug Revenue (2018-2029) & (USD Million)
Figure 12. India Based Company Botanical Drug Revenue (2018-2029) & (USD Million)
Figure 13. Botanical Drug Market Drivers
Figure 14. Factors Affecting Demand
Figure 15. World Botanical Drug Consumption Value (2018-2029) & (USD Million)
Figure 16. World Botanical Drug Consumption Value Market Share by Region (2018-2029)
Figure 17. United States Botanical Drug Consumption Value (2018-2029) & (USD Million)
Figure 18. China Botanical Drug Consumption Value (2018-2029) & (USD Million)
Figure 19. Europe Botanical Drug Consumption Value (2018-2029) & (USD Million)
Figure 20. Japan Botanical Drug Consumption Value (2018-2029) & (USD Million)
Figure 21. South Korea Botanical Drug Consumption Value (2018-2029) & (USD Million)
Figure 22. ASEAN Botanical Drug Consumption Value (2018-2029) & (USD Million)
Figure 23. India Botanical Drug Consumption Value (2018-2029) & (USD Million)
Figure 24. Producer Shipments of Botanical Drug by Player Revenue ($MM) and Market Share (%): 2022
Figure 25. Global Four-firm Concentration Ratios (CR4) for Botanical Drug Markets in 2022
Figure 26. Global Four-firm Concentration Ratios (CR8) for Botanical Drug Markets in 2022
Figure 27. United States VS China: Botanical Drug Revenue Market Share Comparison (2018 & 2022 & 2029)
Figure 28. United States VS China: Botanical Drug Consumption Value Market Share Comparison (2018 & 2022 & 2029)
Figure 29. World Botanical Drug Market Size by Type, (USD Million), 2018 & 2022 & 2029
Figure 30. World Botanical Drug Market Size Market Share by Type in 2022
Figure 31. Prescription Drug
Figure 32. OTC
Figure 33. World Botanical Drug Market Size Market Share by Type (2018-2029)
Figure 34. World Botanical Drug Market Size by Application, (USD Million), 2018 & 2022 & 2029
Figure 35. World Botanical Drug Market Size Market Share by Application in 2022
Figure 36. Cardiovascular
Figure 37. Tumor
Figure 38. Respiratory System
Figure 39. Other
Figure 40. Botanical Drug Industrial Chain
Figure 41. Methodology
Figure 42. Research Process and Data Source
Table 1. World Botanical Drug Revenue by Region (2018, 2022 and 2029) & (USD Million), (by Headquarter Location)
Table 2. World Botanical Drug Revenue by Region (2018-2023) & (USD Million), (by Headquarter Location)
Table 3. World Botanical Drug Revenue by Region (2024-2029) & (USD Million), (by Headquarter Location)
Table 4. World Botanical Drug Revenue Market Share by Region (2018-2023), (by Headquarter Location)
Table 5. World Botanical Drug Revenue Market Share by Region (2024-2029), (by Headquarter Location)
Table 6. Major Market Trends
Table 7. World Botanical Drug Consumption Value Growth Rate Forecast by Region (2018 & 2022 & 2029) & (USD Million)
Table 8. World Botanical Drug Consumption Value by Region (2018-2023) & (USD Million)
Table 9. World Botanical Drug Consumption Value Forecast by Region (2024-2029) & (USD Million)
Table 10. World Botanical Drug Revenue by Player (2018-2023) & (USD Million)
Table 11. Revenue Market Share of Key Botanical Drug Players in 2022
Table 12. World Botanical Drug Industry Rank of Major Player, Based on Revenue in 2022
Table 13. Global Botanical Drug Company Evaluation Quadrant
Table 14. Head Office of Key Botanical Drug Player
Table 15. Botanical Drug Market: Company Product Type Footprint
Table 16. Botanical Drug Market: Company Product Application Footprint
Table 17. Botanical Drug Mergers & Acquisitions Activity
Table 18. United States VS China Botanical Drug Market Size Comparison, (2018 & 2022 & 2029) & (USD Million)
Table 19. United States VS China Botanical Drug Consumption Value Comparison, (2018 & 2022 & 2029) & (USD Million)
Table 20. United States Based Botanical Drug Companies, Headquarters (States, Country)
Table 21. United States Based Companies Botanical Drug Revenue, (2018-2023) & (USD Million)
Table 22. United States Based Companies Botanical Drug Revenue Market Share (2018-2023)
Table 23. China Based Botanical Drug Companies, Headquarters (Province, Country)
Table 24. China Based Companies Botanical Drug Revenue, (2018-2023) & (USD Million)
Table 25. China Based Companies Botanical Drug Revenue Market Share (2018-2023)
Table 26. Rest of World Based Botanical Drug Companies, Headquarters (States, Country)
Table 27. Rest of World Based Companies Botanical Drug Revenue, (2018-2023) & (USD Million)
Table 28. Rest of World Based Companies Botanical Drug Revenue Market Share (2018-2023)
Table 29. World Botanical Drug Market Size by Type, (USD Million), 2018 & 2022 & 2029
Table 30. World Botanical Drug Market Size by Type (2018-2023) & (USD Million)
Table 31. World Botanical Drug Market Size by Type (2024-2029) & (USD Million)
Table 32. World Botanical Drug Market Size by Application, (USD Million), 2018 & 2022 & 2029
Table 33. World Botanical Drug Market Size by Application (2018-2023) & (USD Million)
Table 34. World Botanical Drug Market Size by Application (2024-2029) & (USD Million)
Table 35. Buchang Pharmaceuticals Basic Information, Area Served and Competitors
Table 36. Buchang Pharmaceuticals Major Business
Table 37. Buchang Pharmaceuticals Botanical Drug Product and Services
Table 38. Buchang Pharmaceuticals Botanical Drug Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 39. Buchang Pharmaceuticals Recent Developments/Updates
Table 40. Buchang Pharmaceuticals Competitive Strengths & Weaknesses
Table 41. China TCM Basic Information, Area Served and Competitors
Table 42. China TCM Major Business
Table 43. China TCM Botanical Drug Product and Services
Table 44. China TCM Botanical Drug Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 45. China TCM Recent Developments/Updates
Table 46. China TCM Competitive Strengths & Weaknesses
Table 47. Tsumura Basic Information, Area Served and Competitors
Table 48. Tsumura Major Business
Table 49. Tsumura Botanical Drug Product and Services
Table 50. Tsumura Botanical Drug Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 51. Tsumura Recent Developments/Updates
Table 52. Tsumura Competitive Strengths & Weaknesses
Table 53. Schwabe Basic Information, Area Served and Competitors
Table 54. Schwabe Major Business
Table 55. Schwabe Botanical Drug Product and Services
Table 56. Schwabe Botanical Drug Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 57. Schwabe Recent Developments/Updates
Table 58. Schwabe Competitive Strengths & Weaknesses
Table 59. Tong Ren Tang Basic Information, Area Served and Competitors
Table 60. Tong Ren Tang Major Business
Table 61. Tong Ren Tang Botanical Drug Product and Services
Table 62. Tong Ren Tang Botanical Drug Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 63. Tong Ren Tang Recent Developments/Updates
Table 64. Tong Ren Tang Competitive Strengths & Weaknesses
Table 65. Jumpcan Pharmaceutical Basic Information, Area Served and Competitors
Table 66. Jumpcan Pharmaceutical Major Business
Table 67. Jumpcan Pharmaceutical Botanical Drug Product and Services
Table 68. Jumpcan Pharmaceutical Botanical Drug Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 69. Jumpcan Pharmaceutical Recent Developments/Updates
Table 70. Jumpcan Pharmaceutical Competitive Strengths & Weaknesses
Table 71. Guangzhou Baiyunshan Pharmaceutical Basic Information, Area Served and Competitors
Table 72. Guangzhou Baiyunshan Pharmaceutical Major Business
Table 73. Guangzhou Baiyunshan Pharmaceutical Botanical Drug Product and Services
Table 74. Guangzhou Baiyunshan Pharmaceutical Botanical Drug Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 75. Guangzhou Baiyunshan Pharmaceutical Recent Developments/Updates
Table 76. Guangzhou Baiyunshan Pharmaceutical Competitive Strengths & Weaknesses
Table 77. Yunnan Baiyao Basic Information, Area Served and Competitors
Table 78. Yunnan Baiyao Major Business
Table 79. Yunnan Baiyao Botanical Drug Product and Services
Table 80. Yunnan Baiyao Botanical Drug Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 81. Yunnan Baiyao Recent Developments/Updates
Table 82. Yunnan Baiyao Competitive Strengths & Weaknesses
Table 83. Tasly Holding Group Basic Information, Area Served and Competitors
Table 84. Tasly Holding Group Major Business
Table 85. Tasly Holding Group Botanical Drug Product and Services
Table 86. Tasly Holding Group Botanical Drug Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 87. Tasly Holding Group Recent Developments/Updates
Table 88. Tasly Holding Group Competitive Strengths & Weaknesses
Table 89. Bionorica Se Basic Information, Area Served and Competitors
Table 90. Bionorica Se Major Business
Table 91. Bionorica Se Botanical Drug Product and Services
Table 92. Bionorica Se Botanical Drug Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 93. Bionorica Se Recent Developments/Updates
Table 94. Bionorica Se Competitive Strengths & Weaknesses
Table 95. Huarun 999 Basic Information, Area Served and Competitors
Table 96. Huarun 999 Major Business
Table 97. Huarun 999 Botanical Drug Product and Services
Table 98. Huarun 999 Botanical Drug Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 99. Huarun 999 Recent Developments/Updates
Table 100. Huarun 999 Competitive Strengths & Weaknesses
Table 101. Taiji Basic Information, Area Served and Competitors
Table 102. Taiji Major Business
Table 103. Taiji Botanical Drug Product and Services
Table 104. Taiji Botanical Drug Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 105. Taiji Recent Developments/Updates
Table 106. Taiji Competitive Strengths & Weaknesses
Table 107. Weleda Basic Information, Area Served and Competitors
Table 108. Weleda Major Business
Table 109. Weleda Botanical Drug Product and Services
Table 110. Weleda Botanical Drug Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 111. Weleda Recent Developments/Updates
Table 112. Weleda Competitive Strengths & Weaknesses
Table 113. Kwangdong Basic Information, Area Served and Competitors
Table 114. Kwangdong Major Business
Table 115. Kwangdong Botanical Drug Product and Services
Table 116. Kwangdong Botanical Drug Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 117. Kwangdong Recent Developments/Updates
Table 118. GW Pharmaceuticals Basic Information, Area Served and Competitors
Table 119. GW Pharmaceuticals Major Business
Table 120. GW Pharmaceuticals Botanical Drug Product and Services
Table 121. GW Pharmaceuticals Botanical Drug Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 122. Global Key Players of Botanical Drug Upstream (Raw Materials)
Table 123. Botanical Drug Typical Customers
LIST OF FIGURE
Figure 1. Botanical Drug Picture
Figure 2. World Botanical Drug Total Market Size: 2018 & 2022 & 2029, (USD Million)
Figure 3. World Botanical Drug Total Market Size (2018-2029) & (USD Million)
Figure 4. World Botanical Drug Revenue Market Share by Region (2018, 2022 and 2029) & (USD Million) , (by Headquarter Location)
Figure 5. World Botanical Drug Revenue Market Share by Region (2018-2029), (by Headquarter Location)
Figure 6. United States Based Company Botanical Drug Revenue (2018-2029) & (USD Million)
Figure 7. China Based Company Botanical Drug Revenue (2018-2029) & (USD Million)
Figure 8. Europe Based Company Botanical Drug Revenue (2018-2029) & (USD Million)
Figure 9. Japan Based Company Botanical Drug Revenue (2018-2029) & (USD Million)
Figure 10. South Korea Based Company Botanical Drug Revenue (2018-2029) & (USD Million)
Figure 11. ASEAN Based Company Botanical Drug Revenue (2018-2029) & (USD Million)
Figure 12. India Based Company Botanical Drug Revenue (2018-2029) & (USD Million)
Figure 13. Botanical Drug Market Drivers
Figure 14. Factors Affecting Demand
Figure 15. World Botanical Drug Consumption Value (2018-2029) & (USD Million)
Figure 16. World Botanical Drug Consumption Value Market Share by Region (2018-2029)
Figure 17. United States Botanical Drug Consumption Value (2018-2029) & (USD Million)
Figure 18. China Botanical Drug Consumption Value (2018-2029) & (USD Million)
Figure 19. Europe Botanical Drug Consumption Value (2018-2029) & (USD Million)
Figure 20. Japan Botanical Drug Consumption Value (2018-2029) & (USD Million)
Figure 21. South Korea Botanical Drug Consumption Value (2018-2029) & (USD Million)
Figure 22. ASEAN Botanical Drug Consumption Value (2018-2029) & (USD Million)
Figure 23. India Botanical Drug Consumption Value (2018-2029) & (USD Million)
Figure 24. Producer Shipments of Botanical Drug by Player Revenue ($MM) and Market Share (%): 2022
Figure 25. Global Four-firm Concentration Ratios (CR4) for Botanical Drug Markets in 2022
Figure 26. Global Four-firm Concentration Ratios (CR8) for Botanical Drug Markets in 2022
Figure 27. United States VS China: Botanical Drug Revenue Market Share Comparison (2018 & 2022 & 2029)
Figure 28. United States VS China: Botanical Drug Consumption Value Market Share Comparison (2018 & 2022 & 2029)
Figure 29. World Botanical Drug Market Size by Type, (USD Million), 2018 & 2022 & 2029
Figure 30. World Botanical Drug Market Size Market Share by Type in 2022
Figure 31. Prescription Drug
Figure 32. OTC
Figure 33. World Botanical Drug Market Size Market Share by Type (2018-2029)
Figure 34. World Botanical Drug Market Size by Application, (USD Million), 2018 & 2022 & 2029
Figure 35. World Botanical Drug Market Size Market Share by Application in 2022
Figure 36. Cardiovascular
Figure 37. Tumor
Figure 38. Respiratory System
Figure 39. Other
Figure 40. Botanical Drug Industrial Chain
Figure 41. Methodology
Figure 42. Research Process and Data Source
